French drugmaker Sanofi (SASY.PA) and Verily, the life sciences unit of Google parent Alphabet Inc(GOOGL.O), on Monday said they would invest about $500 million in a joint venture combining devices with services to improve diabetes care, an example of growing ties between the pharma and tech sectors. Sanofi said last year it was working on a partnership with Google in diabetes. "The company will leverage Verily's experience in miniaturised electronics, analytics, and consumer software development, with Sanofi's clinical expertise and experience in bringing innovative treatments to people living with diabetes," the two companies said in a statement. Read more